Invesco Next Gen Connectivity ETF (PXQ) Chart & Stock Price History → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free PXQ Stock Alerts $89.34 -0.09 (-0.10%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Invesco Next Gen Connectivity ETF Stock Price Performance5 Day Performance+2.34%1 Month Performance-4.16%3 Month Performance-3.10%6 Month Performance+16.39%Year-To-Date Performance+0.07%1 Year Performance+25.46% Receive PXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Next Gen Connectivity ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... PXQ Stock Chart for Thursday, April, 25, 2024 PXQ Chart by TradingView Invesco Next Gen Connectivity ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$87.73$89.43+1.94%$89.43$89.4316 shs$38.46 million04/23/2024$77.72$87.73+12.88%$87.73$87.271,521 shs$37.72 million04/22/2024$87.39$77.72-11.06%$77.72$76.6211,200 shs$33.42 million04/19/2024$89.17$88.45-0.81%$88.95$88.241,246 shs$38.04 million04/18/2024$89.17$89.17$90.28$89.17202 shs$38.35 million04/17/2024$90.53$89.17-1.50%$90.28$89.17202 shs$38.35 million Get the Latest News and Ratings for PXQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Next Gen Connectivity ETF and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$91.66$90.53-1.23%$91.82$90.433,115 shs$38.93 million04/15/2024$91.66$91.66$91.66$91.6655 shs$39.41 million04/12/2024$92.28$91.66-0.68%$91.66$91.6655 shs$39.41 million04/11/2024$93.72$92.28-1.53%$92.68$91.85480 shs$47.06 million04/10/2024$93.72$93.72$93.72$93.72188 shs$47.80 million04/09/2024$93.13$93.72+0.63%$93.72$93.72188 shs$47.80 million04/08/2024$93.25$93.13-0.13%$93.13$93.1385 shs$47.50 million04/05/2024$94.03$92.89-1.22%$95.11$92.89471 shs$47.37 million04/04/2024$94.03$94.03$94.40$94.031,026 shs$47.96 million04/03/2024$94.28$94.03-0.26%$94.40$94.031,026 shs$47.96 million04/02/2024$94.12$94.28+0.17%$94.62$94.172,368 shs$48.08 million04/01/2024$94.12$94.12$94.30$93.864,350 shs$48.00 million03/29/2024$94.12$94.12$94.30$93.864,350 shs$48.00 million03/28/2024$93.95$94.12+0.18%$94.30$93.864,340 shs$48.00 million03/27/2024$93.31$93.95+0.69%$93.95$93.57323 shs$47.91 million03/26/2024$93.31$93.31-0.01%$93.31$93.3142 shs$47.59 million03/25/2024$93.51$93.31-0.21%$93.31$93.3197 shs$47.59 million03/22/2024$93.07$93.73+0.71%$93.73$93.7350 shs$47.80 million03/21/2024$91.97$93.07+1.19%$93.07$92.241,588 shs$47.47 million03/20/2024$91.96$91.97+0.01%$91.97$91.52113 shs$46.91 million03/19/2024$91.96$91.96$92.32$91.96533 shs$46.90 million03/18/2024$91.82$91.96+0.15%$92.32$91.96533 shs$46.90 million03/15/2024$93.41$92.75-0.71%$92.92$92.73745 shs$47.30 million03/14/2024$94.35$93.41-0.99%$93.72$93.41889 shs$47.64 million03/13/2024$93.53$94.35+0.88%$94.46$93.631,127 shs$48.12 million03/12/2024$94.10$93.53-0.61%$94.06$92.942,479 shs$47.70 million03/11/2024$94.10$94.10$95.74$94.095,270 shs$47.99 million03/08/2024$94.13$95.83+1.81%$95.87$95.304,226 shs$48.87 million03/07/2024$92.84$94.13+1.38%$94.78$94.132,903 shs$48.01 million03/06/2024$94.54$92.84-1.80%$92.84$92.8419 shs$47.35 million03/05/2024$94.00$94.54+0.58%$94.92$94.494,508 shs$48.22 million03/04/2024$94.00$94.00$94.17$93.155,261 shs$47.94 million03/01/2024$91.80$92.38+0.63%$92.38$92.3851 shs$47.11 million02/29/2024$92.10$91.80-0.33%$91.80$91.71382 shs$46.82 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/28/2024$92.02$92.10+0.09%$92.12$91.851,400 shs$46.97 million02/27/2024$91.82$92.02+0.22%$92.22$92.02912 shs$46.93 million02/26/2024$91.82$91.82$92.15$91.82882 shs$46.83 million02/23/2024$89.88$91.75+2.08%$91.75$91.56125 shs$46.79 million02/22/2024$90.98$89.88-1.21%$89.88$88.99327 shs$45.84 million02/21/2024$91.02$90.98-0.04%$90.98$90.601,575 shs$46.40 million02/20/2024$77.72$91.02+17.11%$91.57$91.01473 shs$46.42 million02/19/2024$91.02$77.72-14.61%$77.72$76.6211,200 shs$39.64 million02/16/2024$92.07$91.02-1.14%$91.57$91.01473 shs$46.42 million02/15/2024$91.15$92.07+1.01%$92.29$91.79880 shs$46.96 million02/14/2024$91.15$91.15$91.61$90.932,719 shs$46.49 million02/13/2024$92.86$91.15-1.85%$91.61$90.932,719 shs$46.49 million02/12/2024$92.86$92.86$92.86$92.52886 shs$47.36 million02/09/2024$92.30$92.30$92.38$92.091,534 shs$47.07 million02/08/2024$90.74$92.30+1.73%$92.38$92.091,534 shs$47.07 million02/07/2024$90.74$90.74$90.74$90.7464 shs$46.28 million02/06/2024$90.94$90.74-0.23%$90.74$90.7464 shs$46.28 million02/05/2024$90.94$90.94$90.95$90.51288 shs$46.38 million02/02/2024$90.24$90.89+0.72%$90.89$90.17108 shs$46.35 million02/01/2024$91.56$90.24-1.44%$90.86$90.241,542 shs$46.02 million01/31/2024$92.27$91.56-0.76%$91.56$91.56152 shs$46.70 million01/30/2024$91.54$92.27+0.79%$92.27$91.66413 shs$47.06 million01/29/2024$91.54$91.54$91.70$91.54261 shs$46.69 million01/26/2024$92.29$92.29$92.95$92.29448 shs$47.07 million01/25/2024$92.34$92.29-0.05%$92.95$92.29448 shs$47.07 million01/24/2024$92.34$92.34$92.34$91.96589 shs$47.09 million Related Companies: Columbia Seligman Semiconductor and Technology ETF Stock Chart India Internet & Ecommerce ETF Stock Chart iShares U.S. Digital Infrastructure and Real Estate ETF Stock Chart SP Funds S&P Global Technology ETF Stock Chart KraneShares Emerging Markets Consumer Technology ETF Stock Chart Strive U.S. Semiconductor ETF Stock Chart SP Funds S&P World (ex-US) ETF Stock Chart Global X Information Technology Covered Call & Growth ETF Stock Chart ProShares UltraShort Semiconductors Stock Chart Xtrackers Semiconductor Select Equity ETF Stock Chart Receive PXQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Next Gen Connectivity ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PXQ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Next Gen Connectivity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.